NCT01667133 2022-06-13A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)TakedaPhase 1/2 Completed35 enrolled 36 charts
NCT02265731 2021-08-02Study Evaluating Venetoclax in Subjects With Hematological MalignanciesAbbViePhase 1/2 Completed38 enrolled
NCT00701844 2017-11-17Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant SurvivorsUniversity of North Carolina, Chapel HillPhase NA Completed315 enrolled
NCT01466179 2017-08-18Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Amgen Research (Munich) GmbHPhase 2 Completed225 enrolled 24 charts
NCT01209286 2017-03-06Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)Amgen Research (Munich) GmbHPhase 2 Completed36 enrolled 24 charts
NCT01471782 2017-02-08Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaAmgen Research (Munich) GmbHPhase 1/2 Completed93 enrolled 21 charts
NCT00283101 2014-12-18A Safety Study in Patients With Chronic Lymphocytic LeukemiaSeagen Inc.Phase 1/2 Completed12 enrolled